SLG
TRIL

Stanley-Laman Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Stanley-Laman Group’s Portfolio TRIL Stock Details TRIL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
2018
Q3 		$809K Buy
2018
Q2 		$823K Buy
2018
Q1 		$779K Buy